Inhibitors of the interaction between MDM2 and p53

Details Inhibitors of the interaction between MDM2 and p53 Inhibitors of the interaction between MDM2 and p53

2005-09-16

2010-11-16

Saeed, Kamal A (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S253090, C514S265100, C514S299000, C514S314000, C514S340000, C544S238000, C544S280000, C544S364000, C546S160000, C546S183000, C546S269400, C546S277400

Reexamination Certificate

active

07834016

ABSTRACT:
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I)wherein n, m, p, s, t, R1, R2, R3, R4, R5, R6, R7, X, Y, Q and Z have defined meanings.

REFERENCES:
patent: 6448277 (2002-09-01), Altmann et al.
patent: 6861448 (2005-03-01), Brouillette et al.
patent: 6878720 (2005-04-01), Altmann et al.
patent: 7002022 (2006-02-01), Altmann et al.
patent: 7122547 (2006-10-01), Huth et al.
patent: 1129074 (2001-09-01), None
patent: 1317443 (2003-06-01), None
patent: 1379239 (2007-09-01), None
patent: 11130750 (1999-05-01), None
patent: WO 93/15047 (1993-08-01), None
patent: WO 00/15357 (2000-03-01), None
patent: WO 01/42224 (2001-06-01), None
patent: WO 02/078693 (2002-10-01), None
patent: WO 03/040402 (2003-05-01), None
patent: WO 03/041715 (2003-05-01), None
patent: WO 03/051359 (2003-06-01), None
patent: WO 2004/005278 (2004-01-01), None
patent: WO 2006/067465 (2006-06-01), None
patent: WO 2007/115289 (2007-10-01), None
Sausville et al. (Cancer Research, 2006, vol. 66, pp. 3351-3354).
Finney, D.J., Probit Analyses, 2ndEd. Chapter 10, Graded Responses, Cambridge University Press, Cambridge 1962.
Vousden K.H., Cell, vol. 103, 691-694, 2000.

Affiliated with

Also associated with

Rating

Inhibitors of the interaction between MDM2 and p53 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of the interaction between MDM2 and p53, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of the interaction between MDM2 and p53 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4231521